Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, 3 Way Crossover Study Evaluating The Relative Abuse Potential Of Crushed Embeda Compared To Morphine Sulfate Controlled Release Tablets (Crushed) And Placebo In Non-Dependent, Recreational Opioid Users Following Intranasal Administration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Morphine/naltrexone (Primary) ; Morphine
- Indications Opioid-related disorders
- Focus Pharmacodynamics
- Sponsors Pfizer
- 16 May 2012 New trial record